American Herbal Products Association (AHPA) > News > AHPA Reports

AHPA Reports

AHPA's monthly newsletter. Members log in to access issues of the AHPA Report.

April 2021 AHPA Report

AHPA Members, Log in to access the AHPA Report

The April 2021 AHPA Report includes: AHPA Welcomes New Board Trustees & Officers; The 2011 – 2017 Tonnage survey of Select North American Wild-Harvested Plants has been released; AHPA 9th Botanical Congress; AHPA Board of Trustees takes action during March 2021 Meetings; AHPA Annual Member Meeting review; and more!

March 2021 AHPA Report

AHPA Members, Log in to access the AHPA Report

The March 2021 AHPA Report includes: AHPA Spring 2021 Meeting & Event Schedule; FDA Guidance Webinar; AHPA continues engagement with NIH’s National Center for Complementary and Integrative Health (NCCIH); and more!

February 2021 AHPA Report

AHPA Members, Log in to access the AHPA Report

The February 2021 AHPA Report includes: AHPA expands COVID Web Center; AHPA Annual Member Meeting; AHPA is hiring: Manager of Communications & Marketing; The US regulatory and legislative landscape in 2021 and beyond; and more!

January 2021 AHPA Report

AHPA Members, Log in to access the AHPA Report

The January 2021 AHPA Report includes: AHPA is hiring: Manager of Communications & Marketing; Noted physician touts nutrition’s critical role in supporting immune health for congressional staff; New safety information added to Botanical Safety Handbook; AHPA attends FDA public meetings clarifying proposed food traceability rule; AHPA attends Cosmetic Ingredients Review meeting.

December 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The December 2020 AHPA Report includes: AHPA promotes Amber Bennett to new VP position; Ransomware Protection: How Safe is Your Data?; AHPA Webinar: Post-Election Download - Free and On-Demand; Call for candidates to AHPA's Board of Trustees; Nominations now being accepted for 2021 AHPA Awards and more.

November 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The November 2020 AHPA Report includes: AHPA Sports Nutrition Congress: A Grand Slam!; AHPA has released updates via the online Botanical Safety Handbook 2nd ed.; AHPA Chief Science Officer Dr. Holly Johnson to present at Whole Plant Expo; FDA issues proposed rule for traceability on "certain foods"; and more.

October 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The October 2020 AHPA Report includes: Inaugural Sports Nutrition Congress; Scientists step up to the plate at the AHPA Sports Nutrition Congress; The Vitamin Shoppe joins the AHPA Sports Nutrition Congress All-Star lineup!; AHPA President Michael McGuffin named to Nutritional Outlook Editorial Board; AHPA attends Cosmetic Ingredient Review meeting finalizing Scutellaria derived cosmetic ingredient safety reports; and more.

September 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The September 2020 AHPA Report includes: Inaugural Sports Nutrition Congress; Hemp-CBD Supplement Congress now on-demand; 9th Annual Botanical Congress; AHPA seeks more time for small firms to comply with new labeling rules; Statement on oleandrin; Senator hoping for sensible guidance on CBD; Hemp-CBD market growth; and more.

August 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The August 2020 AHPA Report includes: FDA announces resumption of domestic inspections; Daily consumption of certain cranberry products reduces risk of recurrent UTIs; Final guidance on BE labeling; Virtual Hemp-CBD Supplement Congress on Aug. 27; and more.

July 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The July  2020 AHPA Report includes AHPA goes virtual, postal service funding request, sustainability webinar on July 22, updated CA Prop 65 guidance, revised CITES primer, FTC proposed rule for 'Made in the USA,' and more.

FDA and FTC highlight attention to intravenous therapies and social media in COVID-19 warning letters

Excerpt from the June 2020 AHPA Report

Since the first week of March, the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have been issuing warning letters alleging that marketers promoted a wide variety of products with claims to prevent, treat, mitigate, diagnose or cure COVID-19. AHPA has analyzed 135 COVID-19 related warning letters issued by either FDA or FTC or by the agencies jointly between March 6, 2020, and May 11, 2020, and made available in each agency’s coronavirus information center as of May 15, 2020.

June 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The June 2020 AHPA Report includes snapshots of global COVID-19 responses that impact the international supplement industry, FDA & FTC COVID-19 warning letters target social media and intravenous therapies, RFP for slippery elm  sustainable wild harvest study, updated Hemp-CBD Status Report, and more.

May 2020 AHPA Report & 2019 Annual Report

AHPA Members, Log in to access the AHPA Report

The May 2020 AHPA Report includes the 2019 AHPA Annual Report, the 2020 AHPA Awards, AOAC Official Method of Analysis for cannabinoids in hemp, free cGMP webinars, AHPA advocacy in Oregon, supply chain issues, and more.

April 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The April 2020 AHPA Report covers COVID-19, including a message from AHPA President Michael McGuffin, free resources and information for the herbal community and a summary of recent federal announcements about FDA inspections and supplement manufacturers and employees being designated as essential.

March 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The March 2020 AHPA Report includes a discussion of proposals to make supplement regulation more efficient and effective, the Cannabis Committee's 10-year anniversary, AERs and supplement safety, postponed events and an update on international supplement regulation from IADSA.

RSS
12345678910 Last

2021 Annual Fund Sponsors

    

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.